Today’s Mental Health System Presents Far Greater Risks to Women Than Men – Even More So for Pregnant Women and Women of Color https://t.co/u9bWDpqaRP via @CCHRSTL
The Novelty of Auvelity (Not) https://t.co/QxBYDAdzCG via @CCHRSTL
Auvelity is an oral psychiatric drug initially approved by the FDA in August 2022 for adults with Major Depressive Disorder (MDD).
CCHR Traveling Exhibit Draws Hundreds of Visitors in Kansas City Area, Exposing Psychiatric Abuse and Drug Risks
Nine-day exhibit in Independence, Missouri, educated the public on psychiatric human rights violations.
https://t.co/CGcgyWMGu1 via @CCHRSTL
CCHR Protests at Psychiatric Convention, Condemning Coercive Psychiatric Treatment and Electroshock
Protesters called on psychiatrists to eliminate electroshock and coercive psychiatric practices.https://t.co/xCYnY75eX7 via @CCHRSTL
Invitation to the "Psychiatry: An Industry of Death" Traveling Exhibit - https://t.co/xr4rttZCkL
Please attend the Grand Opening, Monday March 16, 2026 at 6:00PM.
New Study Details Abuse of Patients by Staff at Inpatient Psychiatric Facilities - https://t.co/zYZewzAbY7
Patients report physical, psychological, and sexual abuse, neglect, and human rights violations that leave them feeling lonely, humiliated, and powerless.
New Study Raises Major Concerns About Questionnaire Widely Used for Depression Screening - https://t.co/t9CYndsO3N
A new study calls into question the validity of the Patient Health Questionnaire (PHQ)
Data Reveals Forced Electroshock in Connecticut More Than Doubled over the Past Decade - https://t.co/394Yq5HbFU
Connecticut stands as an example of the growing problem of electroconvulsive therapy (ECT) performed on patients without their consent.